Recently, El-Deiry and co-workers found that the imidazole-type molecule CB002 is a p53 pathway-restoring compound that induces tumor selective cell death via the induction of NOXA, a pro-apoptotic protein, being able of targeting mutant versions of p53 for MDM2-independent proteasomal degradation. This evidence concerns the gene TP53 and neoplasm.